Fuliang Chu

3.3k total citations · 1 hit paper
39 papers, 2.0k citations indexed

About

Fuliang Chu is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Fuliang Chu has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 20 papers in Oncology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Fuliang Chu's work include Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). Fuliang Chu is often cited by papers focused on Immune Cell Function and Interaction (17 papers), CAR-T cell therapy research (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). Fuliang Chu collaborates with scholars based in United States, China and United Kingdom. Fuliang Chu's co-authors include Sattva S. Neelapu, Chen Dong, Roza Nurieva, Seema Rawal, Shinya Tanaka, Gustavo Martínez, Hoyong Lim, Joseph M. Reynolds, Yeonseok Chung and Yi-Hong Wang and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Fuliang Chu

39 papers receiving 1.9k citations

Hit Papers

Follicular regulatory T cells expressing Foxp3 and Bcl-6 ... 2011 2026 2016 2021 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions
    2011 877 citations Yeonseok Chung, Shinya Tanaka et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuliang Chu United States 19 1.4k 386 310 214 191 39 2.0k
Montserrat Cols United States 18 1.2k 0.9× 127 0.3× 453 1.5× 134 0.6× 116 0.6× 26 1.9k
Anne Lehtonen Finland 14 1.1k 0.8× 486 1.3× 374 1.2× 100 0.5× 141 0.7× 17 1.6k
Akemi Kosaka Japan 21 1.1k 0.8× 580 1.5× 573 1.8× 219 1.0× 95 0.5× 41 1.6k
Sergio Arce United States 19 1.2k 0.9× 247 0.6× 279 0.9× 206 1.0× 97 0.5× 37 1.9k
Micah J. Benson United States 10 1.9k 1.4× 450 1.2× 579 1.9× 154 0.7× 118 0.6× 17 2.7k
Daniel DiToro United States 10 2.1k 1.5× 397 1.0× 330 1.1× 103 0.5× 105 0.5× 16 2.5k
Wataru Ise Japan 23 3.0k 2.2× 533 1.4× 760 2.5× 201 0.9× 102 0.5× 41 3.8k
Nadia Vezzio Canada 11 1.3k 1.0× 463 1.2× 268 0.9× 110 0.5× 145 0.8× 11 2.0k
Ana Ízcue Germany 16 1.8k 1.3× 382 1.0× 425 1.4× 110 0.5× 110 0.6× 20 2.3k
Rolien de Jong Netherlands 19 1.6k 1.2× 325 0.8× 279 0.9× 375 1.8× 203 1.1× 24 2.2k

Countries citing papers authored by Fuliang Chu

Since Specialization
Citations

This map shows the geographic impact of Fuliang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuliang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuliang Chu more than expected).

Fields of papers citing papers by Fuliang Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuliang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuliang Chu. The network helps show where Fuliang Chu may publish in the future.

Co-authorship network of co-authors of Fuliang Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Fuliang Chu. A scholar is included among the top collaborators of Fuliang Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuliang Chu. Fuliang Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Shuying, Wenbin Liu, Mihai Gagea, et al.. (2023). Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Breast Cancer Research. 25(1). 62–62. 20 indexed citations
2.
Chu, Fuliang, Jingjing Cao, Jingwei Liu, et al.. (2023). Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas. Journal for ImmunoTherapy of Cancer. 11(11). e007515–e007515. 9 indexed citations
3.
Nastoupil, Loretta J., Jason R. Westin, Nathan Fowler, et al.. (2022). Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma. Blood Advances. 6(4). 1143–1151. 29 indexed citations
4.
Chu, Fuliang, et al.. (2018). Versatile CAR T-cells for cancer immunotherapy. Współczesna Onkologia. 2018(1). 73–80. 18 indexed citations
5.
Weng, Jinsheng, Fuliang Chu, Sung-Doo Kim, et al.. (2016). IL-15 enhances the antitumor effect of human antigen-specific CD8+T cells by cellular senescence delay. OncoImmunology. 5(12). e1237327–e1237327. 20 indexed citations
6.
Liu, Xindong, Xin Chen, Bo Zhong, et al.. (2014). Transcription factor achaete-scute homologue 2 initiates follicular T-helper-cell development. Nature. 507(7493). 513–518. 254 indexed citations
7.
Chu, Fuliang & Sattva S. Neelapu. (2014). Anti-PD-1 antibodies for the treatment of B-cell lymphoma. OncoImmunology. 3(3). e28101–e28101. 5 indexed citations
8.
Chu, Fuliang, Songbing He, Jing Yu, et al.. (2014). Abstract 4094: Identification of co-inhibitory receptor expression on T cells from gastric cancer patients. Cancer Research. 74(19_Supplement). 4094–4094. 1 indexed citations
9.
Chung, Yeonseok, Shinya Tanaka, Fuliang Chu, et al.. (2011). Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nature Medicine. 17(8). 983–988. 877 indexed citations breakdown →
10.
Chen, Weihong, Feng Gao, Fuliang Chu, et al.. (2010). Crystal Structure of a Bony Fish β2-Microglobulin. Journal of Biological Chemistry. 285(29). 22505–22512. 25 indexed citations
11.
12.
Qian, Xiaomin, Jianxun Qi, Fuliang Chu, et al.. (2009). Crystallization and preliminary X-ray analysis of the V domain of human nectin-2. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 65(6). 615–617. 1 indexed citations
13.
Chu, Fuliang, Myriam Foglietta, Hong Qin, et al.. (2009). In Vitro and In Vivo Effects of CT-011, a Humanized Anti–PD-1 Monoclonal Antibody, in Combination with Rituximab against Human B-Cell Lymphomas.. Blood. 114(22). 724–724. 2 indexed citations
14.
Chen, Yong, Feng Gao, Fuliang Chu, et al.. (2009). Crystal Structure of Myeloid Cell Activating Receptor Leukocyte Ig-like Receptor A2 (LILRA2/ILT1/LIR-7) Domain Swapped Dimer: Molecular Basis for Its Non-binding to MHC Complexes. Journal of Molecular Biology. 386(3). 841–853. 18 indexed citations
15.
Chen, Weihong, Fuliang Chu, Hao Peng, et al.. (2008). Expression, purification, crystallization and preliminary X-ray diffraction analysis of grass carp β2-microglobulin. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 64(3). 200–202. 3 indexed citations
16.
Chu, Fuliang, Zhiyong Lou, Yu Wai Chen, et al.. (2007). First Glimpse of the Peptide Presentation by Rhesus Macaque MHC Class I: Crystal Structures of Mamu-A*01 Complexed with Two Immunogenic SIV Epitopes and Insights into CTL Escape. The Journal of Immunology. 178(2). 944–952. 32 indexed citations
17.
Chen, Yong, Fuliang Chu, Feng Gao, Bin Zhou, & George F. Gao. (2007). Stability engineering, biophysical, and biological characterization of the myeloid activating receptor immunoglobulin-like transcript 1 (ILT1/LIR-7/LILRA2). Protein Expression and Purification. 56(2). 253–260. 15 indexed citations
18.
Chu, Fuliang, Zhiyong Lou, Bin Gao, et al.. (2005). Complex assembly, crystallization and preliminary X-ray crystallographic studies of rhesus macaque MHC Mamu-A*01 complexed with an immunodominant SIV-Gag nonapeptide. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 61(6). 614–616. 12 indexed citations
19.
Xu, Dawei, Zhidong Zhang, Lei Jin, et al.. (2005). Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. European Journal of Clinical Microbiology & Infectious Diseases. 24(3). 165–171. 89 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Montserrat Cols Breakdown of academic impact, for papers by Anne Lehtonen Breakdown of academic impact, for papers by Akemi Kosaka Breakdown of academic impact, for papers by Sergio Arce Breakdown of academic impact, for papers by Micah J. Benson Breakdown of academic impact, for papers by Daniel DiToro Breakdown of academic impact, for papers by Wataru Ise Breakdown of academic impact, for papers by Nadia Vezzio Breakdown of academic impact, for papers by Ana Ízcue Breakdown of academic impact, for papers by Rolien de Jong
Rankless by CCL
2026